Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Dexmedetomidine
(D00514)		[1] Dexmedetomidine[1] Dexmedetomidine (D00514) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[14] 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
2Dexmedetomidine 1
(D00514)		[1] Dexmedetomidine[1] Dexmedetomidine (D00514) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
3Dexmedetomidine 2
(D00514)		[1] Dexmedetomidine[1] Dexmedetomidine (D00514) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
4Dexmedetomidine 3
(D00514)		[1] Dexmedetomidine[1] Dexmedetomidine (D00514) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 280 💬
5Dexmedetomidine group
(D00514)		[1] Dexmedetomidine[1] Dexmedetomidine (D00514) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70 💬
6Dexmedetomidine Hcl 100 Mcg/mL Inj
(D00514)		[1] Dexmedetomidine[1] Dexmedetomidine (D00514) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 215 💬
7DEXMEDETOMIDINE HYDROCHLORIDE
(D00514)		[1] Dexmedetomidine[1] Dexmedetomidine (D00514) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 70 💬
8Dexmedetomidine Hydrochloride Infusion
(D00514)		[1] Dexmedetomidine[1] Dexmedetomidine (D00514) 💬[3] ADRA2A,
ADRA2B,
ADRA2C 💬		[2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 6 💬
9Dexmedetomidine with ropivacaine
(D00514)		[2] Dexmedetomidine,
Ropivacaine		[2] Dexmedetomidine (D00514),
Ropivacaine 💬		[8] ADRA2A,
ADRA2B,
ADRA2C,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬		[5] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Neuroactive ligand-receptor interaction, Taste transduction, cGMP-PKG signaling pathway 💬[1] 70 💬
10Fentanyl (Low Dose) + Dexmedetomidine
(D00514)		[2] Dexmedetomidine,
Fentanyl		[2] Fentanyl ,
Dexmedetomidine (D00514) 💬		[4] ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		[4] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬[1] 215 💬
11Scopolamine, atropine, edaravone and dexmedetomidine
(D00514)		[4] Atropine,
Dexmedetomidine,
Edaravone,
Scopolamine		[4] Atropine ,
Scopolamine ,
Dexmedetomidine (D00514),
Edaravone 💬		[8] ADRA2A,
ADRA2B,
ADRA2C,
CHRM1,
CHRM2,
CHRM3,
CHRM4,
CHRM5 💬		[14] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2 💬